KIMS Subsidiary Receives ₹12.42 Crore GST Demand Order from Tax Authorities
Krishna Institute of Medical Sciences disclosed that its subsidiary Spanv Medisearch Lifesciences received a GST demand order worth ₹12.42 crores from Nagpur tax authorities. The demand relates to alleged non-payment of GST on medicines consumed for inpatients during FY 2021-22, with the company currently examining the matter through legal and tax advisors.

*this image is generated using AI for illustrative purposes only.
Krishna Institute of Medical Sciences Limited has informed stock exchanges about a significant GST demand order received by its subsidiary company. The healthcare major disclosed this development under regulatory compliance requirements.
GST Demand Details
Spanv Medisearch Lifesciences Private Limited, a subsidiary of Krishna Institute of Medical Sciences Limited, received a demand order from the Office of the Deputy Commissioner of State Tax (GST) Nagpur. The order was issued under section 73 read with rule 100(1), 100(2), 100(3) & 142(5).
| Parameter: | Details |
|---|---|
| Demand Amount: | ₹12.42 crores |
| Total Amount (with interest & penalty): | ₹12,42,46,602.68 |
| Issuing Authority: | Deputy Commissioner of State Tax (GST) Nagpur |
| Financial Year: | 2021-22 |
Nature of Alleged Violation
The GST demand order is based on alleged non-payment of GST on medicines consumed for inpatients during the specified financial year. The tax authorities have raised concerns about the company's GST compliance specifically related to pharmaceutical supplies used in inpatient care services.
Company's Response Strategy
Krishna Institute of Medical Sciences Limited stated that the company is currently examining the matter in consultation with its legal and tax advisors. The management has indicated that appropriate steps will be taken as per applicable laws to address the demand order.
| Action Item: | Status |
|---|---|
| Legal Consultation: | In Progress |
| Tax Advisory Review: | Ongoing |
| Appeal Options: | Being Explored |
| Compliance Assessment: | Under Examination |
Regulatory Compliance
The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company provided detailed information as required under Para A of Part-A of Schedule III, ensuring full transparency with stakeholders regarding this material development.
The company has assured that it will explore all available legal options, including filing an appeal before the relevant appellant authority. The subsidiary will work through appropriate legal channels to resolve this tax matter.
Historical Stock Returns for Krishna Institute of Medical Sciences
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.23% | -2.18% | -10.07% | -8.54% | +3.03% | +208.99% |













































